10-Q Filing

SWK Holdings Corp CIK: 1089907 Q3 2025

Filing Information

Form Type	10-Q
Accession Number	`0001628280-25-050155`
Period End Date	20250930
Filing Date	20251106
Fiscal Year	2025
Fiscal Period	Q3
XBRL Instance	swkh-20250930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 164 Income Statement 232 Cash Flow Statement 238 Stockholders Equity 92

Balance Sheet 164 line items

Line Item	Tag	Value	Unit	Period
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$13.90M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$13.90M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$14.34M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$14.34M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$11.25M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$11.25M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$7.74M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$7.74M	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.21M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.21M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$5.79M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$5.79M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$5.58M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$5.58M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Assets held for sale, net (Note 4)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.40M	USD	Point-in-time
Assets held for sale, net (Note 4)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.40M	USD	Point-in-time
Assets held for sale, net (Note 4)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Assets held for sale, net (Note 4)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.14M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.14M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$543.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$543.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.25M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.25M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.33M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.33M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.21M	shares	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.21M	shares	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.10M	shares	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.10M	shares	Point-in-time
Finance receivables, net of allowance for credit losses of $7,740 and $11,249 as of September 30, 2025 and December 31, 2024, respectively	`NotesAndLoansReceivableNetNoncurrent`	$277.76M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $7,740 and $11,249 as of September 30, 2025 and December 31, 2024, respectively	`NotesAndLoansReceivableNetNoncurrent`	$277.76M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $7,740 and $11,249 as of September 30, 2025 and December 31, 2024, respectively	`NotesAndLoansReceivableNetNoncurrent`	$245.40M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $7,740 and $11,249 as of September 30, 2025 and December 31, 2024, respectively	`NotesAndLoansReceivableNetNoncurrent`	$245.40M	USD	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	-	USD	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	-	USD	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.10M	shares	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.10M	shares	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$580.00K	USD	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$580.00K	USD	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$275.00K	USD	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$275.00K	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$23.48M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$23.48M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$19.33M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$19.33M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.76M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.76M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$2.03M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$2.03M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$4.37M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$4.37M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$7.60M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$7.60M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.04M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.04M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$432.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$432.00K	USD	Point-in-time
Total assets	`Assets`	$332.24M	USD	Point-in-time
Total assets	`Assets`	$332.24M	USD	Point-in-time
Total assets	`Assets`	$289.36M	USD	Point-in-time
Total assets	`Assets`	$289.36M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.81M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.81M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.87M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.87M	USD	Point-in-time
Liabilities held for sale (Note 4)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.25M	USD	Point-in-time
Liabilities held for sale (Note 4)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.25M	USD	Point-in-time
Liabilities held for sale (Note 4)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Liabilities held for sale (Note 4)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	$1.50M	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	$1.50M	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.57M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.57M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.87M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.87M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$31.41M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$31.41M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$31.92M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$31.92M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$6.23M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$6.23M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	-	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	-	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$335.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$335.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$361.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$361.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$43.55M	USD	Point-in-time
Total liabilities	`Liabilities`	$43.55M	USD	Point-in-time
Total liabilities	`Liabilities`	$35.16M	USD	Point-in-time
Total liabilities	`Liabilities`	$35.16M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock $0.001 par value; 250,000,000 shares authorized; 12,095,979 and 12,213,599 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock $0.001 par value; 250,000,000 shares authorized; 12,095,979 and 12,213,599 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock $0.001 par value; 250,000,000 shares authorized; 12,095,979 and 12,213,599 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock $0.001 par value; 250,000,000 shares authorized; 12,095,979 and 12,213,599 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.13B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.13B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.16B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.16B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$280.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$280.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$279.89M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$279.89M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$282.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$282.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$283.43M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$283.43M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$288.69M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$288.69M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$292.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$292.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$246.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$246.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$254.21M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$254.21M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$332.24M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$332.24M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$289.36M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$289.36M	USD	Point-in-time

Income Statement 232 line items

Line Item	Tag	Value	Unit	Period
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$9.50M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$9.50M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$30.52M	USD	3 Qtrs
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$30.52M	USD	3 Qtrs
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$10.82M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$10.82M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$30.08M	USD	3 Qtrs
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$30.08M	USD	3 Qtrs
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$628.00K	USD	1 Quarter
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$628.00K	USD	1 Quarter
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.71M	USD	3 Qtrs
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.71M	USD	3 Qtrs
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.15M	USD	3 Qtrs
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.15M	USD	3 Qtrs
Other	`OtherIncome`	$292.00K	USD	1 Quarter
Other	`OtherIncome`	$292.00K	USD	1 Quarter
Other	`OtherIncome`	$395.00K	USD	3 Qtrs
Other	`OtherIncome`	$395.00K	USD	3 Qtrs
Other	`OtherIncome`	$60.00K	USD	1 Quarter
Other	`OtherIncome`	$60.00K	USD	1 Quarter
Other	`OtherIncome`	$536.00K	USD	3 Qtrs
Other	`OtherIncome`	$536.00K	USD	3 Qtrs
Total revenues	`Revenues`	$10.42M	USD	1 Quarter
Total revenues	`Revenues`	$10.42M	USD	1 Quarter
Total revenues	`Revenues`	$32.62M	USD	3 Qtrs
Total revenues	`Revenues`	$32.62M	USD	3 Qtrs
Total revenues	`Revenues`	$10.88M	USD	1 Quarter
Total revenues	`Revenues`	$10.88M	USD	1 Quarter
Total revenues	`Revenues`	$32.77M	USD	3 Qtrs
Total revenues	`Revenues`	$32.77M	USD	3 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$1.39M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$1.39M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$10.78M	USD	3 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$10.78M	USD	3 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-931.00K	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-931.00K	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-1.64M	USD	3 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-1.64M	USD	3 Qtrs
Loss on impairment of intangibles assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Loss on impairment of intangibles assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Loss on impairment of intangibles assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$5.77M	USD	3 Qtrs
Loss on impairment of intangibles assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$5.77M	USD	3 Qtrs
Loss on impairment of intangibles assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$209.00K	USD	1 Quarter
Loss on impairment of intangibles assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$209.00K	USD	1 Quarter
Loss on impairment of intangibles assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$209.00K	USD	3 Qtrs
Loss on impairment of intangibles assets	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$209.00K	USD	3 Qtrs
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	-	USD	1 Quarter
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	-	USD	1 Quarter
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	-	USD	3 Qtrs
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	-	USD	3 Qtrs
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	$314.00K	USD	1 Quarter
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	$314.00K	USD	1 Quarter
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	$314.00K	USD	3 Qtrs
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	$314.00K	USD	3 Qtrs
Interest expense	`InterestExpenseOperating`	$1.14M	USD	1 Quarter
Interest expense	`InterestExpenseOperating`	$1.14M	USD	1 Quarter
Interest expense	`InterestExpenseOperating`	$3.51M	USD	3 Qtrs
Interest expense	`InterestExpenseOperating`	$3.51M	USD	3 Qtrs
Interest expense	`InterestExpenseOperating`	$1.18M	USD	1 Quarter
Interest expense	`InterestExpenseOperating`	$1.18M	USD	1 Quarter
Interest expense	`InterestExpenseOperating`	$3.46M	USD	3 Qtrs
Interest expense	`InterestExpenseOperating`	$3.46M	USD	3 Qtrs
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$585.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$585.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.64M	USD	3 Qtrs
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.64M	USD	3 Qtrs
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$147.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$147.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.55M	USD	3 Qtrs
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.55M	USD	3 Qtrs
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	-	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	-	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	$4.90M	USD	3 Qtrs
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	$4.90M	USD	3 Qtrs
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	-	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	-	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	-	USD	3 Qtrs
Change in fair value of acquisition-related contingent consideration	`AcquisitionRelatedContingentConsiderationFairValueAdjustment`	-	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$234.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$234.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.17M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.17M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$40.00K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$40.00K	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$2.99M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$2.99M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$8.60M	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$8.60M	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$3.29M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$3.29M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$9.41M	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$9.41M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$4.08M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$4.08M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$6.06M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$6.06M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$6.68M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$6.68M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$19.42M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$19.42M	USD	3 Qtrs
Unrealized net gains on warrants	`UnrealizedGainLossOnDerivatives`	$47.00K	USD	1 Quarter
Unrealized net gains on warrants	`UnrealizedGainLossOnDerivatives`	$47.00K	USD	1 Quarter
Unrealized net gains on warrants	`UnrealizedGainLossOnDerivatives`	$178.00K	USD	3 Qtrs
Unrealized net gains on warrants	`UnrealizedGainLossOnDerivatives`	$178.00K	USD	3 Qtrs
Unrealized net gains on warrants	`UnrealizedGainLossOnDerivatives`	$2.64M	USD	1 Quarter
Unrealized net gains on warrants	`UnrealizedGainLossOnDerivatives`	$2.64M	USD	1 Quarter
Unrealized net gains on warrants	`UnrealizedGainLossOnDerivatives`	$2.56M	USD	3 Qtrs
Unrealized net gains on warrants	`UnrealizedGainLossOnDerivatives`	$2.56M	USD	3 Qtrs
Net gain on exercise and cancellation of warrants	`NetGainOnExerciseAndCancellationOfWarrants`	-	USD	1 Quarter
Net gain on exercise and cancellation of warrants	`NetGainOnExerciseAndCancellationOfWarrants`	-	USD	1 Quarter
Net gain on exercise and cancellation of warrants	`NetGainOnExerciseAndCancellationOfWarrants`	$444.00K	USD	3 Qtrs
Net gain on exercise and cancellation of warrants	`NetGainOnExerciseAndCancellationOfWarrants`	$444.00K	USD	3 Qtrs
Net gain on exercise and cancellation of warrants	`NetGainOnExerciseAndCancellationOfWarrants`	-	USD	1 Quarter
Net gain on exercise and cancellation of warrants	`NetGainOnExerciseAndCancellationOfWarrants`	-	USD	1 Quarter
Net gain on exercise and cancellation of warrants	`NetGainOnExerciseAndCancellationOfWarrants`	-	USD	3 Qtrs
Net gain on exercise and cancellation of warrants	`NetGainOnExerciseAndCancellationOfWarrants`	-	USD	3 Qtrs
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	3 Qtrs
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	3 Qtrs
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	$-82.00K	USD	3 Qtrs
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	$-82.00K	USD	3 Qtrs
Discontinued operation, gain (loss) on disposal of discontinued operation, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	-	USD	1 Quarter
Discontinued operation, gain (loss) on disposal of discontinued operation, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	-	USD	1 Quarter
Discontinued operation, gain (loss) on disposal of discontinued operation, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	-	USD	3 Qtrs
Discontinued operation, gain (loss) on disposal of discontinued operation, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	-	USD	3 Qtrs
Discontinued operation, gain (loss) on disposal of discontinued operation, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$1.60M	USD	1 Quarter
Discontinued operation, gain (loss) on disposal of discontinued operation, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$1.60M	USD	1 Quarter
Discontinued operation, gain (loss) on disposal of discontinued operation, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$1.60M	USD	3 Qtrs
Discontinued operation, gain (loss) on disposal of discontinued operation, net of tax	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$1.60M	USD	3 Qtrs
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-6.00K	USD	1 Quarter
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-6.00K	USD	1 Quarter
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-168.00K	USD	3 Qtrs
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-168.00K	USD	3 Qtrs
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-246.00K	USD	1 Quarter
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-246.00K	USD	1 Quarter
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-314.00K	USD	3 Qtrs
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-314.00K	USD	3 Qtrs
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	-	USD	1 Quarter
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	-	USD	1 Quarter
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	-	USD	3 Qtrs
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	-	USD	3 Qtrs
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	-	USD	1 Quarter
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	-	USD	1 Quarter
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	$1.73M	USD	3 Qtrs
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	$1.73M	USD	3 Qtrs
Gain (loss) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Gain (loss) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Gain (loss) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	3 Qtrs
Gain (loss) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	3 Qtrs
Gain (loss) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Gain (loss) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Gain (loss) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$-3.73M	USD	3 Qtrs
Gain (loss) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$-3.73M	USD	3 Qtrs
Realized and unrealized foreign currency transaction gains (losses)	`ForeignCurrencyTransactionGainLossBeforeTax`	$251.00K	USD	1 Quarter
Realized and unrealized foreign currency transaction gains (losses)	`ForeignCurrencyTransactionGainLossBeforeTax`	$251.00K	USD	1 Quarter
Realized and unrealized foreign currency transaction gains (losses)	`ForeignCurrencyTransactionGainLossBeforeTax`	$775.00K	USD	3 Qtrs
Realized and unrealized foreign currency transaction gains (losses)	`ForeignCurrencyTransactionGainLossBeforeTax`	$775.00K	USD	3 Qtrs
Realized and unrealized foreign currency transaction gains (losses)	`ForeignCurrencyTransactionGainLossBeforeTax`	$25.00K	USD	1 Quarter
Realized and unrealized foreign currency transaction gains (losses)	`ForeignCurrencyTransactionGainLossBeforeTax`	$25.00K	USD	1 Quarter
Realized and unrealized foreign currency transaction gains (losses)	`ForeignCurrencyTransactionGainLossBeforeTax`	$-113.00K	USD	3 Qtrs
Realized and unrealized foreign currency transaction gains (losses)	`ForeignCurrencyTransactionGainLossBeforeTax`	$-113.00K	USD	3 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.37M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.37M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.79M	USD	3 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.79M	USD	3 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$10.70M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$10.70M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$21.07M	USD	3 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$21.07M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$906.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$906.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$2.17M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$2.17M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$1.92M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.92M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$4.22M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$4.22M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.47M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.47M	USD	1 Quarter
Net income	`NetIncomeLoss`	$7.62M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$7.62M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$8.78M	USD	1 Quarter
Net income	`NetIncomeLoss`	$8.78M	USD	1 Quarter
Net income	`NetIncomeLoss`	$16.86M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$16.86M	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.28	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.28	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.61	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.61	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.72	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.72	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.38	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.38	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.28	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.28	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.61	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.61	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.72	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.72	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.38	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.38	USD	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.32M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.32M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.42M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.42M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.12M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.12M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.18M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.18M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.41M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.41M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.49M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.49M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.12M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.12M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.18M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.18M	shares	3 Qtrs

Cash Flow Statement 238 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.47M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.47M	USD	1 Quarter
Net income	`NetIncomeLoss`	$7.62M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$7.62M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$8.78M	USD	1 Quarter
Net income	`NetIncomeLoss`	$8.78M	USD	1 Quarter
Net income	`NetIncomeLoss`	$16.86M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$16.86M	USD	3 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$1.39M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$1.39M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$10.78M	USD	3 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$10.78M	USD	3 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-931.00K	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-931.00K	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-1.64M	USD	3 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-1.64M	USD	3 Qtrs
Loss on sale of assets	`GainLossOnSaleOfOtherAssets`	-	USD	3 Qtrs
Loss on sale of assets	`GainLossOnSaleOfOtherAssets`	-	USD	3 Qtrs
Loss on sale of assets	`GainLossOnSaleOfOtherAssets`	$-82.00K	USD	3 Qtrs
Loss on sale of assets	`GainLossOnSaleOfOtherAssets`	$-82.00K	USD	3 Qtrs
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsFinitelived`	$5.77M	USD	3 Qtrs
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsFinitelived`	$5.77M	USD	3 Qtrs
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsFinitelived`	$209.00K	USD	3 Qtrs
Loss on impairment of intangible assets	`ImpairmentOfIntangibleAssetsFinitelived`	$209.00K	USD	3 Qtrs
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$339.00K	USD	3 Qtrs
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$339.00K	USD	3 Qtrs
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$143.00K	USD	3 Qtrs
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$143.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$775.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$775.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$850.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$850.00K	USD	3 Qtrs
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$2.10M	USD	3 Qtrs
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$2.10M	USD	3 Qtrs
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$4.16M	USD	3 Qtrs
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$4.16M	USD	3 Qtrs
Unrealized net gain on warrants	`FairValueAdjustmentOfWarrants`	$-178.00K	USD	3 Qtrs
Unrealized net gain on warrants	`FairValueAdjustmentOfWarrants`	$-178.00K	USD	3 Qtrs
Unrealized net gain on warrants	`FairValueAdjustmentOfWarrants`	$-2.56M	USD	3 Qtrs
Unrealized net gain on warrants	`FairValueAdjustmentOfWarrants`	$-2.56M	USD	3 Qtrs
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	-	USD	1 Quarter
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	-	USD	1 Quarter
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	-	USD	3 Qtrs
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	-	USD	3 Qtrs
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	$314.00K	USD	1 Quarter
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	$314.00K	USD	1 Quarter
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	$314.00K	USD	3 Qtrs
Loss on disposal of inventory	`GainLossOnDispositionOfInventory`	$314.00K	USD	3 Qtrs
Net gain from exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	$-444.00K	USD	3 Qtrs
Net gain from exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	$-444.00K	USD	3 Qtrs
Net gain from exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	-	USD	3 Qtrs
Net gain from exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	-	USD	3 Qtrs
Gain on sale of business	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Gain on sale of business	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Gain on sale of business	`GainLossOnSaleOfBusiness`	$1.48M	USD	3 Qtrs
Gain on sale of business	`GainLossOnSaleOfBusiness`	$1.48M	USD	3 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionRelatedContingentConsideration`	$-4.90M	USD	3 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionRelatedContingentConsideration`	$-4.90M	USD	3 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionRelatedContingentConsideration`	-	USD	3 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionRelatedContingentConsideration`	-	USD	3 Qtrs
Loss (gain) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Loss (gain) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Loss (gain) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	3 Qtrs
Loss (gain) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	3 Qtrs
Loss (gain) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Loss (gain) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Loss (gain) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$-3.73M	USD	3 Qtrs
Loss (gain) on revaluation of finance receivables	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$-3.73M	USD	3 Qtrs
Foreign currency transaction gains	`ForeignCurrencyTransactionGainLossUnrealized`	$678.00K	USD	3 Qtrs
Foreign currency transaction gains	`ForeignCurrencyTransactionGainLossUnrealized`	$678.00K	USD	3 Qtrs
Foreign currency transaction gains	`ForeignCurrencyTransactionGainLossUnrealized`	$639.00K	USD	3 Qtrs
Foreign currency transaction gains	`ForeignCurrencyTransactionGainLossUnrealized`	$639.00K	USD	3 Qtrs
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-6.00K	USD	1 Quarter
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-6.00K	USD	1 Quarter
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-168.00K	USD	3 Qtrs
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-168.00K	USD	3 Qtrs
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-246.00K	USD	1 Quarter
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-246.00K	USD	1 Quarter
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-314.00K	USD	3 Qtrs
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-314.00K	USD	3 Qtrs
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$2.46M	USD	3 Qtrs
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$2.46M	USD	3 Qtrs
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$5.96M	USD	3 Qtrs
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$5.96M	USD	3 Qtrs
Interest paid-in-kind	`PaidInKindInterestCapitalized`	$1.36M	USD	3 Qtrs
Interest paid-in-kind	`PaidInKindInterestCapitalized`	$1.36M	USD	3 Qtrs
Interest paid-in-kind	`PaidInKindInterestCapitalized`	$1.58M	USD	3 Qtrs
Interest paid-in-kind	`PaidInKindInterestCapitalized`	$1.58M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$708.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$708.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$894.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$894.00K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$234.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$234.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.17M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.17M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$40.00K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$40.00K	USD	3 Qtrs
Interest, accounts receivable and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.69M	USD	3 Qtrs
Interest, accounts receivable and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.69M	USD	3 Qtrs
Interest, accounts receivable and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-207.00K	USD	3 Qtrs
Interest, accounts receivable and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-207.00K	USD	3 Qtrs
Foreign currency forward contract	`IncreaseDecreaseInForeignCurrencyForwardContract`	$-219.00K	USD	3 Qtrs
Foreign currency forward contract	`IncreaseDecreaseInForeignCurrencyForwardContract`	$-219.00K	USD	3 Qtrs
Foreign currency forward contract	`IncreaseDecreaseInForeignCurrencyForwardContract`	$-915.00K	USD	3 Qtrs
Foreign currency forward contract	`IncreaseDecreaseInForeignCurrencyForwardContract`	$-915.00K	USD	3 Qtrs
Collateral returned for foreign currency forward contract	`IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities`	-	USD	3 Qtrs
Collateral returned for foreign currency forward contract	`IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities`	-	USD	3 Qtrs
Collateral returned for foreign currency forward contract	`IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities`	$-2.75M	USD	3 Qtrs
Collateral returned for foreign currency forward contract	`IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities`	$-2.75M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-30.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-30.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-1.27M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-1.27M	USD	3 Qtrs
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.41M	USD	3 Qtrs
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.41M	USD	3 Qtrs
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-387.00K	USD	3 Qtrs
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-387.00K	USD	3 Qtrs
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$2.10M	USD	3 Qtrs
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$2.10M	USD	3 Qtrs
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$-1.50M	USD	3 Qtrs
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$-1.50M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.16M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.16M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.99M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.99M	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$110.00K	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$110.00K	USD	3 Qtrs
Settlement of foreign currency forward contract	`ProceedsFromDerivativeInstrumentInvestingActivities`	-	USD	3 Qtrs
Settlement of foreign currency forward contract	`ProceedsFromDerivativeInstrumentInvestingActivities`	-	USD	3 Qtrs
Settlement of foreign currency forward contract	`ProceedsFromDerivativeInstrumentInvestingActivities`	$1.60M	USD	Point-in-time
Settlement of foreign currency forward contract	`ProceedsFromDerivativeInstrumentInvestingActivities`	$1.60M	USD	Point-in-time
Settlement of foreign currency forward contract	`ProceedsFromDerivativeInstrumentInvestingActivities`	$1.56M	USD	3 Qtrs
Settlement of foreign currency forward contract	`ProceedsFromDerivativeInstrumentInvestingActivities`	$1.56M	USD	3 Qtrs
Proceeds from sale of assets and liabilities held for sale	`ProceedsFromSaleOfAssetsAndLiabilitiesHeldForSale`	-	USD	3 Qtrs
Proceeds from sale of assets and liabilities held for sale	`ProceedsFromSaleOfAssetsAndLiabilitiesHeldForSale`	-	USD	3 Qtrs
Proceeds from sale of assets and liabilities held for sale	`ProceedsFromSaleOfAssetsAndLiabilitiesHeldForSale`	$6.79M	USD	3 Qtrs
Proceeds from sale of assets and liabilities held for sale	`ProceedsFromSaleOfAssetsAndLiabilitiesHeldForSale`	$6.79M	USD	3 Qtrs
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	$574.00K	USD	3 Qtrs
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	$574.00K	USD	3 Qtrs
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	-	USD	3 Qtrs
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	-	USD	3 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$17.74M	USD	3 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$17.74M	USD	3 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$28.50M	USD	3 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$28.50M	USD	3 Qtrs
Proceeds from sale of finance receivables	`ProceedsFromSaleOfFinanceReceivables`	-	USD	3 Qtrs
Proceeds from sale of finance receivables	`ProceedsFromSaleOfFinanceReceivables`	-	USD	3 Qtrs
Proceeds from sale of finance receivables	`ProceedsFromSaleOfFinanceReceivables`	$31.68M	USD	3 Qtrs
Proceeds from sale of finance receivables	`ProceedsFromSaleOfFinanceReceivables`	$31.68M	USD	3 Qtrs
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$30.58M	USD	3 Qtrs
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$30.58M	USD	3 Qtrs
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$34.65M	USD	3 Qtrs
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$34.65M	USD	3 Qtrs
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$20.00K	USD	3 Qtrs
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$20.00K	USD	3 Qtrs
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$23.00K	USD	3 Qtrs
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$23.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$50.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$50.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$512.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$512.00K	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$13.39M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$13.39M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.80M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.80M	USD	3 Qtrs
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	3 Qtrs
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	3 Qtrs
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-89.00K	USD	3 Qtrs
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-89.00K	USD	3 Qtrs
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-12.35M	USD	3 Qtrs
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-12.35M	USD	3 Qtrs
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-6.23M	USD	3 Qtrs
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-6.23M	USD	3 Qtrs
Cash dividends	`PaymentsOfOrdinaryDividends`	-	USD	3 Qtrs
Cash dividends	`PaymentsOfOrdinaryDividends`	-	USD	3 Qtrs
Cash dividends	`PaymentsOfOrdinaryDividends`	$49.08M	USD	3 Qtrs
Cash dividends	`PaymentsOfOrdinaryDividends`	$49.08M	USD	3 Qtrs
Payments of financing costs	`PaymentsOfFinancingCosts`	$50.00K	USD	3 Qtrs
Payments of financing costs	`PaymentsOfFinancingCosts`	$50.00K	USD	3 Qtrs
Payments of financing costs	`PaymentsOfFinancingCosts`	$41.00K	USD	3 Qtrs
Payments of financing costs	`PaymentsOfFinancingCosts`	$41.00K	USD	3 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$5.17M	USD	3 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$5.17M	USD	3 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$3.07M	USD	3 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$3.07M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-17.61M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-17.61M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-58.51M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-58.51M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.94M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.94M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.28M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.28M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.18M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.18M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.21M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.21M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.18M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.18M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.21M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.21M	USD	Point-in-time
Fair value of warrants received with finance receivables	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	$1.07M	USD	3 Qtrs
Fair value of warrants received with finance receivables	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	$1.07M	USD	3 Qtrs
Fair value of warrants received with finance receivables	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	-	USD	3 Qtrs
Fair value of warrants received with finance receivables	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	-	USD	3 Qtrs
Fair value of warrants received with finance receivables	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	$1.07M	USD	3 Qtrs
Fair value of warrants received with finance receivables	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	$1.07M	USD	3 Qtrs
Fair value of warrants received with finance receivables	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	-	USD	3 Qtrs
Fair value of warrants received with finance receivables	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	-	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$2.40M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$2.40M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$2.26M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$2.26M	USD	3 Qtrs
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease`	$82.00K	USD	3 Qtrs
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease`	$82.00K	USD	3 Qtrs
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease`	-	USD	3 Qtrs
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease`	-	USD	3 Qtrs

Stockholders Equity 92 line items

Line Item	Tag	Value	Unit	Period
Special cash dividend declared (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$4.00	USD	1 Quarter
Special cash dividend declared (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$4.00	USD	1 Quarter
Net settlement for employee taxes on stock options	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$43.00K	USD	1 Quarter
Net settlement for employee taxes on stock options	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$43.00K	USD	1 Quarter
Net settlement for employee taxes on stock options	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$89.00K	USD	1 Quarter
Net settlement for employee taxes on stock options	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$89.00K	USD	1 Quarter
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.10M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.10M	shares	Point-in-time
Beginning balance	`StockholdersEquity`	$280.31M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$280.31M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$279.89M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$279.89M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$282.83M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$282.83M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$283.43M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$283.43M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$292.67M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$292.67M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$246.47M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$246.47M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$254.21M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$254.21M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$111.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$111.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$249.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$249.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$348.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$348.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$307.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$307.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$301.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$301.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$286.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$286.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$999.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$999.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$950.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$950.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$3.22M	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$3.22M	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$867.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$867.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$870.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$870.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$1.33M	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$1.33M	USD	1 Quarter
Cash dividends	`DividendsCommonStock`	$49.08M	USD	1 Quarter
Cash dividends	`DividendsCommonStock`	$49.08M	USD	1 Quarter
Net settlement for employee taxes on stock options	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$43.00K	USD	1 Quarter
Net settlement for employee taxes on stock options	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$43.00K	USD	1 Quarter
Net settlement for employee taxes on stock options	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$89.00K	USD	1 Quarter
Net settlement for employee taxes on stock options	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$89.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.68M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.47M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.47M	USD	1 Quarter
Net income	`NetIncomeLoss`	$7.62M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$7.62M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$8.78M	USD	1 Quarter
Net income	`NetIncomeLoss`	$8.78M	USD	1 Quarter
Net income	`NetIncomeLoss`	$16.86M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$16.86M	USD	3 Qtrs
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.10M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.10M	shares	Point-in-time
Ending balance	`StockholdersEquity`	$280.31M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$280.31M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$279.89M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$279.89M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$282.83M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$282.83M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$283.43M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$283.43M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$292.67M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$292.67M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$246.47M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$246.47M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$254.21M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$254.21M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.